Video-assisted speech therapy for patients with ORL cancer
Evaluation of the Interest of a Video-assisted Remote Speech Therapy Consultation in Patients With ORL Cancer (TELE ORTHOPHONIE)
NA · Institut Claudius Regaud · NCT04940000
This study tests if video calls with speech therapists can help patients with head and neck cancer improve their speaking and swallowing skills.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 105 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Institut Claudius Regaud (other) |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Toulouse) |
| Trial ID | NCT04940000 on ClinicalTrials.gov |
What this trial studies
This interventional study evaluates the effectiveness of video-assisted remote speech therapy consultations for patients with ORL cancer, specifically focusing on issues related to phonation and swallowing. Patients will receive consultations from both a private speech therapist and an expert therapist, with their satisfaction assessed through a questionnaire. The study aims to determine how this remote approach can address the complex needs of patients undergoing treatment for advanced ORL cancer.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with T3 or T4 ORL cancer requiring speech therapy.
Not a fit: Patients who are pregnant, lactating, or unable to comply with the study protocol due to psychological or sociological conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance access to specialized speech therapy for ORL cancer patients, improving their quality of life.
How similar studies have performed: While the specific approach of video-assisted consultations is relatively novel, similar telehealth interventions have shown promise in improving patient outcomes in various medical fields.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥ 18 years at study entry. 2. Patient with carcinological pathology of the VADS, relevant to surgery and/or radiotherapy and/or chemotherapy. 3. Patient managed at the IUCT-O and by a private speech therapist (near the patient's home). 4. Patient affiliated to a Social Security system in France. 5. Patient having signed informed consent prior to inclusion in the study and prior to any specific study procedure. Exclusion Criteria: 1. Pregnant or lactating women. 2. Any psychological, familial, geographical or sociological condition that does not allow for compliance with the medical follow-up and/or procedures foreseen in the study protocol. 3. Patients deprived of their liberty or under legal protection (guardianship and tutorship, safeguard of justice).
Where this trial is running
Toulouse
- Institut Universitaire du Cancer de Toulouse - Oncopole — Toulouse, France (RECRUITING)
Study contacts
- Study coordinator: Jérôme SARINI
- Email: sarini.jerome@iuct-oncopole.fr
- Phone: 05 31 15 60 16
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: ORL Cancer, Video-Assisted Speech Therapy